Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)

DUBLIN, Oct. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announced that the CoolSculpting® treatment received FDA clearance to treat the submandibular area. In addition, the FDA clearance was expanded to include... Devices, Dermatology, FDA Allergan, CoolSculpting
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news